Sign in

CIK 0001730430

  • Large accelerated filer

Kiniksa Pharmaceuticals International, plc

Sign in to watch
Ticker
KNSA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
981795578
Phone
+1 781-431-9100
Business address
105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
Former names
Kiniksa Pharmaceuticals, Ltd.
  1. 4 Shares withheld for taxes CHIEF MEDICAL OFFICER gave up 1,686 shares (to pay taxes)
  2. 4 Shares withheld for taxes CHIEF ACCOUNTING OFFICER gave up 1,120 shares (to pay taxes)
  3. 4 Shares withheld for taxes CHIEF OPERATING OFFICER gave up 1,461 shares (to pay taxes)
  4. 4 Grant or award Chief Accounting Officer acquired 2,287 shares (grant or award)
  5. 4 Grant or award Chief Commercial Officer acquired 2,509 shares (grant or award)
  6. 4 Shares withheld for taxes Chief Medical Officer gave up 598 shares (to pay taxes)
  7. 4 Shares withheld for taxes Chairman & CEO gave up 1,922 shares (to pay taxes)
  8. 4 Shares withheld for taxes Chief Financial Officer gave up 303 shares (to pay taxes)
  9. 4 Grant or award Chief Operating Officer acquired 1,838 shares (grant or award)
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 14 of 20 · 386 filings